Chronic disease research is being transformed by digital and decentralized clinical trial solutions that improve patient access, engagement and study efficiency. This webinar will explore how patient-centric recruitment strategies, remote monitoring technologies, hybrid trial models and digital tools are helping advance more flexible, efficient and data-driven chronic disease studies.
The featured speakers will discuss how wearable devices, remote data capture and decentralized approaches can help reduce patient burden, improve participant retention and diversity and enhance operational efficiency and data quality across long-term studies.
Key topics include:
- Improving patient recruitment, retention and diversity through decentralized trial models
- Leveraging remote monitoring, wearables and digital endpoints in chronic disease research
- Implementing hybrid trial approaches that balance technology, sites and patient experience
- Enhancing trial efficiency, oversight and data quality with digital clinical solutions
Register for this webinar to learn how digital and decentralized clinical trial solutions are helping transform chronic disease research into a more patient-centred, efficient and data-driven future.
Speakers
Rose Blackburne, MD, MBA, Vice President, Head of Population Science Strategies and Women’s Health, PPD clinical research business, Thermo Fisher Scientific
Rose Blackburne, MD, MBA is an experienced Healthcare and Global Life Science Executive. She currently serves as Vice President, Head of Population Science Strategies and Women’s Health at Thermo Fisher Scientific. She is passionate about Women’s Health, Health Equity and developing platforms to improve access to real-world patient representation in clinical trials and optimal health outcomes.
She is a globally recognized leader in Medical Product Development and has been instrumental in numerous approvals for pharmaceuticals, vaccines, medical devices and diagnostic tests. She leverages her medical, scientific and regulatory strategic insights to drive approvals for small, midsize and large biotechnology and pharmaceutical companies. She has three decades of clinical leadership expertise in large health care systems and global clinical development in biotechnology and pharmaceutical sectors.
Dr. Blackburne is a board-certified Physician with over 25 years of experience in Health Care. She was a practicing Physician and Principal Investigator for clinical trials prior to her career in the Contract Research Organization (CRO) industry. Dr. Blackburne has over 20 years of Clinical Research & Development experience and has held numerous Global leadership positions across therapeutic areas in Phase I-IV programs.
Dr. Blackburne has been widely recognized for her medical and scientific expertise and contributions to advancing health equity, thought leadership and organizational excellence.
Message Presenter
Jennifer Crager, Executive Director, Digital Implementation, Patient First Digital Solutions, PPD clinical research business, Thermo Fisher Scientific
Jennifer Crager is the Executive Director of Digital Implementation, within Patient First Digital Solutions, at the PPD clinical research business of Thermo Fisher Scientific. She has been in a management role within the clinical research technology space for over 23 years.
Jennifer oversees technology strategies, design and implementation for a wide range of digital solutions including but not limited to eCOA, eConsent, televisit, eSource, CTMS, recruitment technology and wearables.
Jennifer has worked at a number of solution provider companies with oversight of software development, customer support, training, quality assurance, technical delivery and project management.
Message Presenter
Yvette Perjes, Associate Director, DCT Operations, Patient First Digital Solutions, PPD clinical research business, Thermo Fisher Scientific
Yvette Perjes is the Associate Director of DCT Operations within the Patient First Digital Solutions team at the PPD clinical research business of Thermo Fisher Scientific. She is responsible for supporting the operational delivery of decentralized clinical trial (DCT) solutions, helping integrate patient-centric digital strategies into clinical studies to enhance participant experience and improve trial efficiency.
In her role, Yvette collaborates with cross-functional teams, sponsors and technology partners to implement fit-for-purpose decentralized solutions that align with study objectives, operational requirements and regulatory expectations. She also contributes to developing operational standards and best practices that support the successful execution of hybrid and fully decentralized clinical trials.
Yvette is committed to advancing modern, patient-focused clinical research by leveraging digital innovation to improve study delivery, accessibility and data quality.
Message PresenterWho Should Attend?
This webinar will appeal to:
- Clinical Operations professionals involved in decentralized and hybrid clinical trial execution
- Clinical Research leaders and Clinical Trial Managers overseeing chronic disease studies
- Biopharmaceutical and biotech professionals responsible for Clinical Development and Study Strategy
- Digital Health, Data Science and Innovation leaders evaluating digital clinical trial technologies
What You Will Learn
Attendees will learn:
- How digital and decentralized solutions are transforming chronic disease clinical trials by improving patient access, engagement and operational efficiency
- Strategies for implementing patient-centric recruitment, remote monitoring, wearable technologies and hybrid trial models to reduce patient burden and enhance participant retention and diversity
- Best practices for leveraging digital tools and decentralized approaches to improve trial oversight, data quality and long-term study success
Xtalks Partner
The PPD clinical research business of Thermo Fisher Scientific Inc.
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, enables customers to accelerate innovation and increase drug development productivity. Utilizing patient-centered strategies and data analytics, their capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services. Recognized as a global industry leader in accelerating promising medicines from early development through regulatory approval and market access, they serve pharma, biotech, medical device and government organizations with custom-tailored solutions, including full-service partnerships and functional service partnerships. As a strategic partner in clinical development and analytical services, they apply cutting edge technologies, therapeutic expertise and a firm commitment to quality to help customers deliver life-changing therapies.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account